1. Home
  2. RVSB vs PMVP Comparison

RVSB vs PMVP Comparison

Compare RVSB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.66

Market Cap

114.3M

Sector

Finance

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
PMVP
Founded
1923
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.3M
79.5M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
RVSB
PMVP
Price
$5.66
$1.22
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
40.9K
635.4K
Earning Date
04-28-2026
03-06-2026
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
N/A
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$9.82
N/A
P/E Ratio
$30.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.74
$0.82
52 Week High
$6.59
$1.88

Technical Indicators

Market Signals
Indicator
RVSB
PMVP
Relative Strength Index (RSI) 70.54 35.45
Support Level $5.30 $1.12
Resistance Level $5.85 $1.26
Average True Range (ATR) 0.14 0.06
MACD 0.05 -0.05
Stochastic Oscillator 100.00 2.33

Price Performance

Historical Comparison
RVSB
PMVP

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: